Delivery Order SPE2DB20D2104-SPE2DB23FR66U
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The DO, valued at $11,419.27, is for the delivery of 4,555,876,328 units of the prescription medication Vyvanse (10 mg capsules). This contract supports the DLA Troop Support Medical, which provides pharmaceutical and medical supplies to U.S. military...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,009.80 firm fixed price contract is for the delivery of 100 units of the medication Vyvanse 40 mg capsules. The contract has no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that serves as a critical supplier to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00. The contract covers the delivery of 4,563,617,369 units of Vyvanse 30 mg capsules, a specialty medication, to support military and veterans' healthcare programs. The award has a ceiling value of $1,755.19 and an ultimate completion date of February 12, 2024. The...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 through November 2026. The contract covers the delivery of 4,566,765,422 units of Vyvanse 10mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD), for a Firm Fixed Price of $21,403.20. The contract has no set-aside...
- This federal contract award, valued at $3,479.48, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award, valued at $2,108.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the parent company Cencora, Inc. The contract is for the delivery of 4,559,786,330 units of the medication Vyvanse 10 mg capsules. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through November...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,664.86 firm fixed-price delivery order is for the supply of 4,556,775,524 units of Vyvanse 50 mg capsules. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,219.03, is for the delivery of 4,562,853,174 units of Vyvanse 30 mg capsules. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. This IDC serves as the...
- This federal contract award, valued at $1,138.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,212.70, is for the delivery of 4,563,302,824 units of the pharmaceutical drug Vyvanse 30 mg capsules. The award is a delivery order placed against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FR66UDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,783.16, is for the delivery of 4,559,522,849 units of the medication Vyvanse 10 mg chewable tablets. The award is not designated as a set-aside contract and was made through full and open competition. Amerisourcebergen, a major pharmaceutical distributor, has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company's extensive pharmaceutical and medical supply capabilities enable it to efficiently fulfill delivery orders for a wide range of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This specific contract award is part of Amerisourcebergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/5/23 |